UniProt ID | NOTC2_MOUSE | |
---|---|---|
UniProt AC | O35516 | |
Protein Name | Neurogenic locus notch homolog protein 2 | |
Gene Name | Notch2 | |
Organism | Mus musculus (Mouse). | |
Sequence Length | 2470 | |
Subcellular Localization |
Notch 2 extracellular truncation: Cell membrane Single-pass type I membrane protein . Notch 2 intracellular domain: Nucleus . Cytoplasm . Following proteolytical processing NICD is translocated to the nucleus. Retained at the cytoplasm by TCIM. |
|
Protein Description | Functions as a receptor for membrane-bound ligands Jagged1, Jagged2 and Delta1 to regulate cell-fate determination. Upon ligand activation through the released notch intracellular domain (NICD) it forms a transcriptional activator complex with RBPJ/RBPSUH and activates genes of the enhancer of split locus. Affects the implementation of differentiation, proliferation and apoptotic programs (By similarity). May play an essential role in postimplantation development, probably in some aspect of cell specification and/or differentiation. In collaboration with RELA/p65 enhances NFATc1 promoter activity and positively regulates RANKL-induced osteoclast differentiation. Positively regulates self-renewal of liver cancer cells (By similarity).. | |
Protein Sequence | MPDLRPAALRALLWLWLCGAGPAHALQCRGGQEPCVNEGTCVTYHNGTGFCRCPEGFLGEYCQHRDPCEKNRCQNGGTCVPQGMLGKATCRCAPGFTGEDCQYSTSHPCFVSRPCQNGGTCHMLSRDTYECTCQVGFTGKQCQWTDACLSHPCENGSTCTSVASQFSCKCPAGLTGQKCEADINECDIPGRCQHGGTCLNLPGSYRCQCGQGFTGQHCDSPYVRGLPCVNGGTCRQTGDFTLECNCLPGFEGSTCERNIDDCPNHKCQNGGVCVDGVNTYNCRCPPQWTGQFCTEDVDECLLQPNACQNGGTCTNRNGGYGCVCVNGWSGDDCSENIDDCAYASCTPGSTCIDRVASFSCLCPEGKAGLLCHLDDACISNPCHKGALCDTNPLNGQYICTCPQGYKGADCTEDVDECAMANSNPCEHAGKCVNTDGAFHCECLKGYAGPRCEMDINECHSDPCQNDATCLDKIGGFTCLCMPGFKGVHCELEVNECQSNPCVNNGQCVDKVNRFQCLCPPGFTGPVCQIDIDDCSSTPCLNGAKCIDHPNGYECQCATGFTGILCDENIDNCDPDPCHHGQCQDGIDSYTCICNPGYMGAICSDQIDECYSSPCLNDGRCIDLVNGYQCNCQPGTSGLNCEINFDDCASNPCMHGVCVDGINRYSCVCSPGFTGQRCNIDIDECASNPCRKGATCINDVNGFRCICPEGPHHPSCYSQVNECLSNPCIHGNCTGGLSGYKCLCDAGWVGVNCEVDKNECLSNPCQNGGTCNNLVNGYRCTCKKGFKGYNCQVNIDECASNPCLNQGTCFDDVSGYTCHCMLPYTGKNCQTVLAPCSPNPCENAAVCKEAPNFESFSCLCAPGWQGKRCTVDVDECISKPCMNNGVCHNTQGSYVCECPPGFSGMDCEEDINDCLANPCQNGGSCVDHVNTFSCQCHPGFIGDKCQTDMNECLSEPCKNGGTCSDYVNSYTCTCPAGFHGVHCENNIDECTESSCFNGGTCVDGINSFSCLCPVGFTGPFCLHDINECSSNPCLNAGTCVDGLGTYRCICPLGYTGKNCQTLVNLCSRSPCKNKGTCVQEKARPHCLCPPGWDGAYCDVLNVSCKAAALQKGVPVEHLCQHSGICINAGNTHHCQCPLGYTGSYCEEQLDECASNPCQHGATCNDFIGGYRCECVPGYQGVNCEYEVDECQNQPCQNGGTCIDLVNHFKCSCPPGTRGLLCEENIDECAGGPHCLNGGQCVDRIGGYTCRCLPGFAGERCEGDINECLSNPCSSEGSLDCVQLKNNYNCICRSAFTGRHCETFLDVCPQKPCLNGGTCAVASNMPDGFICRCPPGFSGARLQSSCGQVKCRRGEQCIHTDSGPRCFCLNPKDCESGCASNPCQHGGTCYPQRQPPHYSCRCPPSFGGSHCELYTAPTSTPPATCQSQYCADKARDGICDEACNSHACQWDGGDCSLTMEDPWANCTSTLRCWEYINNQCDEQCNTAECLFDNFECQRNSKTCKYDKYCADHFKDNHCDQGCNSEECGWDGLDCASDQPENLAEGTLIIVVLLPPEQLLQDSRSFLRALGTLLHTNLRIKQDSQGALMVYPYFGEKSAAMKKQKMTRRSLPEEQEQEQEVIGSKIFLEIDNRQCVQDSDQCFKNTDAAAALLASHAIQGTLSYPLVSVFSELESPRNAQLLYLLAVAVVIILFFILLGVIMAKRKQAWLPLAAGRFTLRRDSSNHKRREPVGQDAVGLKNLSVQVSEANLIGSGTSEHWVDDEGPQPKKAKAEDEALLSEDDPIDRRPWTQQHLEAADISHTPSLALTPPQAEQEVDVLDVNVRGPDGCTPLMLASLRGGSSDLSDEDEDAEDSSANIITDLVYQGASLQAQTDRTGEMALHLAARYSRADAAKRLLDAGADRNAQDNMGRCPLHAAVAGDAQGVFQILIRNRVTDLDARMNDGTTPLILAARLAVEGMVAELINCQADVNAVDDHGKSALHWAAAVNNVEATLLLLKNGANRDMQDNKEETPLFLAAREGSYEAAKILLDHFANRDITDHMDRLPRDVARDRMHHDIVRLLDEYNVTPSPPGTVLTSALSPVLCGPNRSFLSLKHTPMGKKARRPNTKSTMPTSLPNLAKEAKDAKGSRRKKCLNEKVQLSESSVTLSPVDSLESPHTYVSDATSSPMITSPGILQASPTPLLAAAAPAAPVHTQHALSFSNLHDMQPLAPGASTVLPSVSQLLSHHHIAPPGSSSAGSLGRLHPVPVPADWMNRVEMNETQYSEMFGMVLAPAEGAHPGIAAPQSRPPEGKHMSTQREPLPPIVTFQLIPKRSIAQAAGAPQTQSSCPPAVAGPLPSMYQIPEMPRLPSVAFPPTMMPQQEGQVAQTIVPTYHPFPASVGKYPTPPSQHSYASSNAAERTPSHGGHLQGEHPYLTPSPESPDQWSSSSPHSASDWSDVTTSPTPGGGGGGQRGPGTHMSEPPHSNMQVYA | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
46 | N-linked_Glycosylation | GTCVTYHNGTGFCRC CCEEEEECCCCEECC | 39.03 | - | |
155 | N-linked_Glycosylation | CLSHPCENGSTCTSV HHCCCCCCCCCCHHH | 57.33 | - | |
357 | Phosphorylation | TCIDRVASFSCLCPE CHHHHHHEEEEECCC | 18.16 | 30352176 | |
611 | O-linked_Glycosylation | DQIDECYSSPCLNDG HCCCHHHCCCCCCCC | 39.19 | 21949356 | |
613 | O-linked_Glycosylation | IDECYSSPCLNDGRC CCHHHCCCCCCCCCE | 22.22 | 21949356 | |
733 | N-linked_Glycosylation | PCIHGNCTGGLSGYK CCCCCCCCCCCCCCE | 37.98 | - | |
1102 | N-linked_Glycosylation | YCDVLNVSCKAAALQ CCCCCCCCHHHHHHH | 14.61 | - | |
1465 | N-linked_Glycosylation | EDPWANCTSTLRCWE CCCCCCCCHHHHHHH | 25.26 | - | |
1599 | Acetylation | GEKSAAMKKQKMTRR CCCHHHHHHHHHHHC | 47.53 | 6567351 | |
1600 | Acetylation | EKSAAMKKQKMTRRS CCHHHHHHHHHHHCC | 41.91 | 6567327 | |
1604 | Phosphorylation | AMKKQKMTRRSLPEE HHHHHHHHHCCCCHH | 29.93 | 25619855 | |
1607 | Phosphorylation | KQKMTRRSLPEEQEQ HHHHHHCCCCHHHHH | 45.01 | 30635358 | |
1715 | Phosphorylation | PLAAGRFTLRRDSSN HHHHCCEEECCCCCC | 20.28 | - | |
1718 | Phosphorylation | AGRFTLRRDSSNHKR HCCEEECCCCCCCCC | 51.80 | 23608596 | |
1718 | Phosphorylation | AGRFTLRRDSSNHKR HCCEEECCCCCCCCC | 51.80 | - | |
1721 | Phosphorylation | FTLRRDSSNHKRREP EEECCCCCCCCCCCC | 47.44 | 25338131 | |
1723 | Phosphorylation | LRRDSSNHKRREPVG ECCCCCCCCCCCCCC | 27.26 | 23608596 | |
1724 | Phosphorylation | RRDSSNHKRREPVGQ CCCCCCCCCCCCCCC | 58.35 | 23608596 | |
1740 | Phosphorylation | AVGLKNLSVQVSEAN CCCCCCEEEEEEEEE | 21.64 | 25338131 | |
1744 | Phosphorylation | KNLSVQVSEANLIGS CCEEEEEEEEEECCC | 17.56 | 29514104 | |
1777 | Phosphorylation | AEDEALLSEDDPIDR HHHHHHCCCCCCCCC | 39.57 | 27566939 | |
1780 | Phosphorylation | EALLSEDDPIDRRPW HHHCCCCCCCCCCCC | 37.69 | 25338131 | |
1780 | Phosphorylation | EALLSEDDPIDRRPW HHHCCCCCCCCCCCC | 37.69 | 19144319 | |
1800 | Phosphorylation | EAADISHTPSLALTP HHCCCCCCCCCCCCC | 14.05 | 30635358 | |
1802 | Phosphorylation | ADISHTPSLALTPPQ CCCCCCCCCCCCCCC | 27.68 | 30635358 | |
1803 | Phosphorylation | DISHTPSLALTPPQA CCCCCCCCCCCCCCH | 4.82 | - | |
1805 | Phosphorylation | SHTPSLALTPPQAEQ CCCCCCCCCCCCHHC | 10.03 | - | |
1805 | Phosphorylation | SHTPSLALTPPQAEQ CCCCCCCCCCCCHHC | 10.03 | 30352176 | |
1806 | Phosphorylation | HTPSLALTPPQAEQE CCCCCCCCCCCHHCE | 27.58 | 30635358 | |
1809 | Phosphorylation | SLALTPPQAEQEVDV CCCCCCCCHHCEECE | 59.75 | - | |
1828 | Phosphorylation | VRGPDGCTPLMLASL CCCCCCCCHHHHHHH | 25.61 | 30482847 | |
1839 | Phosphorylation | LASLRGGSSDLSDED HHHHCCCCCCCCCCC | 24.41 | 21743459 | |
1840 | Phosphorylation | ASLRGGSSDLSDEDE HHHCCCCCCCCCCCC | 45.93 | 21659605 | |
1843 | Phosphorylation | RGGSSDLSDEDEDAE CCCCCCCCCCCCCCC | 43.90 | 21659605 | |
1846 | Phosphorylation | SSDLSDEDEDAEDSS CCCCCCCCCCCCCCC | 65.16 | 19144319 | |
1852 | Phosphorylation | EDEDAEDSSANIITD CCCCCCCCCCHHHHH | 23.90 | 29550500 | |
1853 | Phosphorylation | DEDAEDSSANIITDL CCCCCCCCCHHHHHH | 37.34 | 29550500 | |
1858 | Phosphorylation | DSSANIITDLVYQGA CCCCHHHHHHHHCCC | 21.34 | 29550500 | |
2063 | Phosphorylation | IVRLLDEYNVTPSPP HHHHHHHCCCCCCCC | 18.01 | 30635358 | |
2066 | Phosphorylation | LLDEYNVTPSPPGTV HHHHCCCCCCCCCCE | 17.89 | 26745281 | |
2068 | Phosphorylation | DEYNVTPSPPGTVLT HHCCCCCCCCCCEEE | 34.07 | 26745281 | |
2071 | Phosphorylation | NVTPSPPGTVLTSAL CCCCCCCCCEEECCC | 31.66 | - | |
2072 | Phosphorylation | VTPSPPGTVLTSALS CCCCCCCCEEECCCC | 20.37 | 26745281 | |
2075 | Phosphorylation | SPPGTVLTSALSPVL CCCCCEEECCCCCEE | 13.97 | 26643407 | |
2076 | Phosphorylation | PPGTVLTSALSPVLC CCCCEEECCCCCEEE | 24.05 | 26643407 | |
2079 | Phosphorylation | TVLTSALSPVLCGPN CEEECCCCCEEECCC | 16.81 | 27087446 | |
2082 | Phosphorylation | TSALSPVLCGPNRSF ECCCCCEEECCCCCC | 2.95 | - | |
2088 | Phosphorylation | VLCGPNRSFLSLKHT EEECCCCCCCCCCCC | 36.86 | 28725479 | |
2091 | Phosphorylation | GPNRSFLSLKHTPMG CCCCCCCCCCCCCCC | 33.10 | 28725479 | |
2095 | Phosphorylation | SFLSLKHTPMGKKAR CCCCCCCCCCCCCCC | 17.24 | 26370283 | |
2098 | Phosphorylation | SLKHTPMGKKARRPN CCCCCCCCCCCCCCC | 29.52 | - | |
2112 | Phosphorylation | NTKSTMPTSLPNLAK CCCCCCCCCHHHHHH | 31.88 | 26643407 | |
2113 | Phosphorylation | TKSTMPTSLPNLAKE CCCCCCCCHHHHHHH | 35.64 | 26745281 | |
2415 | Phosphorylation | QGEHPYLTPSPESPD CCCCCCCCCCCCCCC | 18.84 | 25338131 | |
2420 | Phosphorylation | YLTPSPESPDQWSSS CCCCCCCCCCCCCCC | 36.84 | 25338131 | |
2426 | Phosphorylation | ESPDQWSSSSPHSAS CCCCCCCCCCCCCCC | 31.69 | 25338131 | |
2441 | Phosphorylation | DWSDVTTSPTPGGGG CCCCCCCCCCCCCCC | 19.87 | 25338131 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
2066 | T | Phosphorylation | Kinase | GSK3B | Q9WV60 | PhosphoELM |
2068 | S | Phosphorylation | Kinase | GSK3B | Q9WV60 | PhosphoELM |
2072 | T | Phosphorylation | Kinase | GSK3B | Q9WV60 | PhosphoELM |
2091 | S | Phosphorylation | Kinase | GSK3B | Q9WV60 | PhosphoELM |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of NOTC2_MOUSE !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of NOTC2_MOUSE !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
EGFL7_HUMAN | EGFL7 | physical | 19503073 | |
EGFL7_MOUSE | Egfl7 | physical | 19503073 |
Kegg Drug | ||||||
---|---|---|---|---|---|---|
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"The phagosomal proteome in interferon-gamma-activated macrophages."; Trost M., English L., Lemieux S., Courcelles M., Desjardins M.,Thibault P.; Immunity 30:143-154(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1777, AND MASSSPECTROMETRY. |